US Draft Bill Highlights Perceived China Biotech Threat

WuXi Scrambles To Avoid TikTok Moment

 
• By Brian Yang

A draft bill from the US House related to national security issues sent WuXi Biologics' shares tumbling over concerns around increased US scrutiny of Chinese firms, which a company clarification did little to dispel.  

WuXi Biologics scrambles to clarify as US scrutiny over China increases • Source: Shutterstock

More from China

More from Focus On Asia